Guru Ownership Trend
Guru Analysis for ANI Pharmaceuticals, Inc. (ANIP)
ANI Pharmaceuticals, Inc. (ANIP), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 7 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $31.25 M.
Top institutional holders include Renaissance Technologies (RenTech) and HOTCHKIS & WILEY.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $16.07 M net outflow during the quarter.
Recent activity highlights Chuck Royce who opened a new position. Conversely, Renaissance Technologies (RenTech) reduced exposure by 40.8%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for ANI Pharmaceuticals, Inc. (ANIP)
Major holders include Renaissance Technologies (RenTech) ($14.31 M), HOTCHKIS & WILEY ($6.39 M), John Hussman ($4.04 M). According to the latest reported data, 7 tracked investment managers collectively hold approximately 400,640 shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $16.07 M, with 4 managers increasing positions and 4 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 2 fully exited ANIP. The total reported sell value was $20.54 M.
Yes, 1 managers opened new positions in ANIP, and 3 increased their existing holdings. The total reported buy value was $4.48 M.
